Sernova Provides Company Outlook on Corporate and Clinical Developments
Sernova Corp., a clinical stage company developing medical technologies for the long-term treatment of chronic metabolic diseases including diabetes, blood disorders such as hemophilia and other diseases, today provided a brief company outlook on corporate and clinical developments.
View full press release